In mouse prostate cancer xenografts, POM121 drives tumor progression through importin-β-dependent nuclear import of androgen receptor, E2F1 and MYC, whereas importin-β inhibitor importazol attenuated tumor growth. The gene discussed is E2F1; the disease is neoplasm.